NEOVACS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 EUR | -.--% |
|
-.--% | -.--% |
| 06-17 | Neovacs: collaboration agreement with CNRS | CF |
| 06-10 | Neovacs: presents results from vaccine candidates | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 39.36B | ||||||
| 38.52B | ||||||
| 30.74B | - | |||||
| 25.92B | ||||||
| 26.03B |
